Developments in Colorectal Cancer Screening: Cell-Free DNA Blood Testing
About this episode
Dr. Peter Buch discusses the potential of cell-free DNA blood tests for colorectal cancer screening with Dr. William Grady.
Host: Peter Buch, MD, FACG, AGAF, FACP Guest: William Grady, MD While colorectal cancer is the second most common cause of cancer deaths, only a third of people between the ages of 45 and 75 are compliant with screening recommendations. However, cell-free DNA blood-based tests could become a new option for colorectal cancer screening. Dr. Peter Buch sits down with GI expert Dr. William Grady to discuss the efficacy of this new test and where it is in the FDA approval process.
More episodes of GI Insights
- Assessing Racial Disparities in Colorectal Cancer Screening
- Recapping the 2021 ACG Clinical Guidelines: What’s New in Colorectal Cancer Screening?
- Strategies for Increasing Colorectal Cancer Screening Rates
- Adenoma Detection Rate: A Prediction of Colorectal Cancer
- Colorectal Cancer in Young Patients: A Multidisciplinary Approach
- Advances in Parenteral Nutrition: Examining Multi-Source Lipid Emulsions
Explore listener stats, chart rankings, contacts and more on the GI Insights podcast page.